Midday Losers From Tuesday, September 2 By: Benzinga via Benzinga September 02, 2014 at 14:15 PM EDT Exelixis (NASDAQ: EXEL) -54% - Shares dropped following disappointing phase 3 trials of Cabozantinib. CONN’S (NASDAQ: CONN) ... Read More >> Related Stocks: Conn's Inc Emerge Energy Services LP Exelixis Inc Las Vegas Sands Ricebran Technologies